| 产品描述: | ALDH1A3-IN-1 (Compound 14) is a potent ALDH1A3 inhibitor, with an IC50 of 0.63 μM and a Ki of 0.46 μM. ALDH1A3-IN-1 can be studied in prostate cancer[1]. |
| 靶点: |
ALDH1;ALDH1A3:0.63 μM (IC50);ALDH1A1:7.08 μM (IC50);ALDH3A1:8.00 μM (IC50);ALDH1A3:0.46 μM (Ki);ALDH1A3:26.92 μM (Km) |
| 体内研究: |
ALDH1A3-IN-1 (Compound 14) (0-200 μM,96 小时) 在前列腺癌细胞系中显示出抗增殖活性[1]。 ALDH1A3-IN-1 (0-200 μM,72 h) 以剂量依赖性方式降低原代前列腺细胞的细胞活力[1]。 |
| 参考文献: |
1. Ali I M Ibrahim, et al. Expansion of the 4-(Diethylamino)benzaldehyde Scaffold to Explore the Impact on Aldehyde Dehydrogenase Activity and Antiproliferative Activity in Prostate Cancer. J Med Chem. 2022 Mar 10;65(5):3833-3848. |
| 保存条件: |
-80°C 6个月; -20°C 1个月,避光 |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
3.519 ml |
17.594 ml |
35.188 ml |
| 5 mM |
0.704 ml |
3.519 ml |
7.038 ml |
| 10 mM |
0.352 ml |
1.759 ml |
3.519 ml |
| 50 mM |
0.07 ml |
0.352 ml |
0.704 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |